Search Results - "Smalley, Richard V."

Allopurinol: Intravenous Use for Prevention and Treatment of Hyperuricemia by SMALLEY, R. V, GUASPARI, A, HAASE-STATZ, S, ANDERSON, S. A, CEDERBERG, D, HOHNEKER, J. A

“…To tabulate data obtained over a 21-year period to determine the efficacy and safety of an intravenous (IV) allopurinol preparation. IV allopurinol was…”
Get full text

Interferon Alfa Combined with Cytotoxic Chemotherapy for Patients with Non-Hodgkin's Lymphoma by Smalley, Richard V, Andersen, Janet W, Hawkins, Michael J, Bhide, Vandana, O'Connell, Michael J, Oken, Martin M, Borden, Ernest C

“…INTERFERON ALFA has been found to be an effective therapeutic agent in patients with low-grade non-Hodgkin's lymphoma. Early studies using both crude natural…”
Get full text

Interferon Alfa plus Chemotherapy for Non-Hodgkin's Lymphoma: Five-Year Follow-up by Smalley, Richard V, Andersen, Janet W

“…To the Editor: As we previously reported (November 5, 1992, issue), 1 interferon alfa, when added to a four-drug, doxorubicin-based chemotherapy regimen, is an…”
Get full text

The superiority of combination chemotherapy over single agent chemotherapy in small cell lung carcinoma by Lowenbraun, S, Bartolucci, A, Smalley, R V, Lynn, M, Krauss, S, Durant, J R

“…From June 1974 to October 1976, 288 patients with small cell undifferentiated lung carcinoma were entered into a randomized, controlled study comparing the two…”
Get more information

Applications of monoclonal antibodies and recombinant cytokines for the treatment of human colorectal and other carcinomas by Greiner, J W, Smalley, R V, Borden, E C, Martin, E W, Guadagni, F, Roselli, M, Schlom, J

“…Monoclonal antibodies (MAbs) which recognize a human tumor antigen, termed tumor-associated glycoprotein-72 (TAG-72), have successfully been used to localize…”
Get more information

Hyperdiploidy in a patient with Di Guglielmo's syndrome by Smalley, R V, Bouroncle, B S

Get more information

The role of immunotherapy in acute myelogenous leukemia by Foon, K A, Smalley, R V, Riggs, C W, Gale, R P

“…The use of immunotherapy for acute myelogenous leukemia (AML) is controversial. Twenty-four trials have been reported in which 1,491 patients with AML received…”
Get more information

Role of interferon-alfa in NHL: still controversial? by Haase-Statz, S, Smalley, R V

“…Recombinant interferon-alfa (Intron A, Roferon-A) has been under investigation as a therapeutic agent for non-Hodgkin's lymphoma (NHL) for 25 years. It has…”
Get more information

Interferon Alfa plus Chemotherapy for Non-Hodgkin's Lymphoma: Five-Year Follow-up: Letter by Andersen, Janet W, Smalley, Richard V

“…To the Editor: As we previously reported (November 5, 1992, issue),1 interferon alfa, when added to a four-drug, doxorubicin-based chemotherapy regimen, is an…”
Get full text

Intraperitoneal administration of interferon-gamma to carcinoma patients enhances expression of tumor-associated glycoprotein-72 and carcinoembryonic antigen on malignant ascites cells by Greiner, J W, Guadagni, F, Goldstein, D, Smalley, R V, Borden, E C, Simpson, J F, Molinolo, A, Schlom, J

“…The study was designed to determine whether in vivo interferon gamma (IFN-gamma) administration could enhance tumor antigen expression on the surface of human…”
Get more information

Vinblastine fails to improve response of renal cancer to interferon alfa-n1: high response rate in patients with pulmonary metastases by Neidhart, J A, Anderson, S A, Harris, J E, Rinehart, J J, Laszlo, J, Dexeus, F H, Einhorn, L H, Trump, D L, Benedetto, P W, Tuttle, R L

“…One hundred sixty-five patients were randomized to receive either interferon alfa-n1 (Wellferon; Burroughs Wellcome Co, Research Triangle Park, NC) alone or…”
Get more information

Hyperthermic perfusion with chemotherapy for melanoma of the extremities by Ghussen, Farid, Krüger, Ingo, Smalley, Richard V., Groth, Wolfgang

“…A prospective randomized study was carried out to evaluate the effectiveness of additional regional cytostatic perfusion of the extremities in patients with…”
Get full text

A comparison of cyclophosphamide, adriamycin, and 5-fluorouracil (CAF) and cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, and prednisone (CMFVP) in patients with advanced breast cancer: A Southeastern Cancer Study Group Project by Smalley, Richard V., Lefante, John, Bartolucci, Alfred, Carpenter, John, Vogel, Charles, Krauss, Stephen

Get full text

Splenectomy vs. alpha interferon: a randomized study in patients with previously untreated hairy cell leukemia by Smalley, R V, Connors, J, Tuttle, R L, Anderson, S, Robinson, W, Whisnant, J K

“…Twenty patients with previously untreated hairy cell leukemia were randomized to undergo either splenectomy or to receive interferon alfa-N1, a highly purified…”
Get more information

A randomized comparison of two doses of human lymphoblastoid interferon-α in hairy cell leukemia by SMALLEY, R. V, ANDERSON, S. A, TUTTLE, R. L, CONNORS, J, THURMOND, L. M, HUANG, A, CASTLE, K, MAGERS, C, WHISNANT, J. K

Get full text

Interferon in the treatment of cancer by Smalley, R V

“…Potential mechanisms of action of interferon in the treatment of cancer are suggested, followed by a discussion on the responsiveness of tumors to…”
Get more information

Front-line hormonal therapy for patients with advanced breast cancer: a community oncology research program by Smalley, R V, Sigal, R B, Anderson, S

“…Megestrol acetate was administered as first-line therapy to 152 patients with advanced breast cancer. Forty-three of 136 evaluable patients (32%) obtained an…”
Get more information

Oral piritrexim : a phase II study in patients with advanced soft tissue sarcoma by SCHIESEL, J. D, CARABASI, M, MAGILL, G, CASPER, E, CHENG, E, MARKS, L, FEYZI, J, CLENDENINN, N. J, SMALLEY, R. V

Get full text

A phase II study of crisnatol mesylate in patients with ovarian carcinoma by SMALLEY, R. V, GOLDSTEIN, D, BULKOWSKI, D, HANNON, C, BUCHLER, D, KNUDSEN, C, TUTTLE, R. L

“…Fourteen patients with advanced ovarian cancer received a 72 hour infusion of a new DNA intercalator, crisnatol mesylate, administered intravenously. There was…”
Get full text

Biological response modifiers: preclinical evaluation and clinical activity by Smalley, R V, Oldham, R K

“…Biological response modifiers are agents capable of affecting the host immune response toward tumors and include those biological substances produced by the…”
Get more information